FDA looks to clarify confirmatory trial mandate for accelerated approvals
In recent years, the FDA has amped up its supervision of accelerated approvals, including by requiring that confirmatory trials at least be underway at the time of these conditional nods. | In a draft guidance document, the FDA specified criteria to determine whether a confirmatory trial is “underway” prior to an accelerated approval.